Edaravone Oral Suspension: A Neuroprotective Agent to Treat Amyotrophic Lateral Sclerosis.
Priya SinghPaul BelliveauJennifer TowleAndrea Elena NeculauLorena DimaPublished in: American journal of therapeutics (2024)
Oral edaravone is an ALS treatment that can be self-administered or administered by a caregiver, precluding the need for administration by a health care professional in an institutional setting.